Breaking News, Collaborations & Alliances

Cygnus, TriLink Jointly Introduce AccuRes Host Cell DNA Quantification Kits

New assay designed to enhance the safety and stability of biotherapeutics.

Author Image

By: Charlie Sternberg

Associate Editor

Maravai LifeSciences subsidiaries Cygnus Technologies and TriLink BioTechnologies have jointly introduced the AccuRes Host Cell DNA Quantification Kits, designed to enhance the safety and stability of biotherapeutics.   The new kits leverage cutting-edge technologies to provide unparalleled sensitivity and specificity in detecting residual host cell DNA, a critical factor in ensuring regulatory compliance. AccuRes utilizes probe-based quantification, ensuring accurate targeting of the specific...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters